Concepedia

Publication | Open Access

The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis

DOIFull Paper Access

44

Citations

30

References

2017

Year

Timothy R. Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, Anthony De Soyza, J.S. Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin Winthrop, Robert C. Wilson
Contemporary Clinical Trials

Abstract

The RESPIRE trials are registered in ClinicalTrials.gov, ID number NCT01764841 (RESPIRE 1; date of registration January 8, 2013) and NCT02106832 (RESPIRE 2; date of registration April 4, 2014).

References

YearCitations

Page 1